IL6 and myocardial infarction: Interleukin-6 (IL-6) is associated with an increased risk of adverse cardiovascular events, especially myocardial infarction, since IL-6 favors the onset of unstable plaque atherosclerosis or increases the inflammatory rate of already present plaques [25].